M, A., G, B., D, C., & ME, P. (2021). CT-P13 subcutaneous infliximab in gastroenterology and rheumatology. Immunotherapy, 13(12), 1001. https://doi.org/10.2217/imt-2020-0339
Chicago Style (17th ed.) CitationM, Ahmed, Bankov G, Casey D, and Perry ME. "CT-P13 Subcutaneous Infliximab in Gastroenterology and Rheumatology." Immunotherapy 13, no. 12 (2021): 1001. https://doi.org/10.2217/imt-2020-0339.
MLA (9th ed.) CitationM, Ahmed, et al. "CT-P13 Subcutaneous Infliximab in Gastroenterology and Rheumatology." Immunotherapy, vol. 13, no. 12, 2021, p. 1001, https://doi.org/10.2217/imt-2020-0339.
Warning: These citations may not always be 100% accurate.